MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Can be stored for up to 28 days only based on manufacturer's stability data.

Provenance

This compatibility recommendation is derived from Janumet 50mg/1000mg tablets (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Exforge 5mg/160mg tablets (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Dapsone 100mg tablets (Accord Healthcare Ltd).

Stability Notes

Caution in handling by female operatives. Avoid handling leaking capsules. Should not be handled by pregnant women and women of childbearing potential.

Provenance

This compatibility recommendation is derived from Combodart 0.5mg/0.4mg capsules (GlaxoSmithKline UK Ltd).

Stability Notes

Data shows stability for up to 4 weeks.

Provenance

This compatibility recommendation is derived from Truvada 200mg/245mg tablets (Gilead Sciences Ltd).

Stability Notes

Should be stored in airtight container. Protect from light

Provenance

This compatibility recommendation is derived from Tildiem 60mg modified-release tablets (Sanofi).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.